Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aquaporins (AQPs) are a family of integral membrane proteins that function as selective channels for water and, in some cases, small solutes like glycerol. In the human colon, the primary isoforms expressed are AQP1, AQP3, AQP4, and AQP8, which are localized to the apical and basolateral membranes of surface epithelial cells and crypts. These proteins are essential for the final stages of fecal dehydration and overall systemic fluid balance by facilitating the rapid reabsorption of water from the intestinal lumen into the bloodstream. Dysregulation of colonic aquaporins is strongly associated with gastrointestinal pathologies; for example, downregulation of AQP3 and AQP8 is observed in patients with ulcerative colitis and Crohn's disease, contributing to the development of diarrhea. Conversely, overexpression of AQP3 and AQP5 has been identified in colorectal cancer tissues, where they promote tumor cell proliferation, migration, and angiogenesis. While specific, clinically approved drugs targeting colonic AQPs are currently limited, they represent a promising therapeutic frontier for treating functional bowel disorders and malignancy through the use of small-molecule inhibitors or expression modulators. Research is ongoing to identify selective modulators that can bypass the safety concerns associated with systemic aquaporin inhibition.
Facilitated diffusion of water and small uncharged solutes across the plasma membrane along osmotic gradients through a narrow, highly selective pore.
3 more in the full profile.
Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aquaporin (AQP).